Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Clinical Biomarkers Market Growth in 2025?

The market size for clinical biomarkers has significantly expanded in the past few years. It is projected to ascend from $30.78 billion in 2024 to $33.85 billion in 2025, marking a compound annual growth rate (CAGR) of 10.0%. The surge observed during the historic period can be traced back to the escalated occurrence of chronic illnesses, an emphasis on bespoke medicine and targeted treatments, progression in drug creation and clinical examinations, in conjunction with regulatory encouragement and financial backing.

What Is the Forecast for the Clinical Biomarkers Market Size Through 2029?

In the next few years, the clinical biomarkers market is projected to experience a swift expansion. It is anticipated to reach a size of $52.8 billion by 2029, with a compound annual growth rate (CAGR) of 11.8%. The projected growth within this period is due to the broadening of companion diagnostics, emphasis on early diagnosis and disease prevention, rising applications in precision oncology and neurodegenerative diseases, and the increase in infectious diseases. Foreseen trends for this period incorporate the use of artificial intelligence for biomarker discovery, the incorporation of machine learning, multi-omics integration, technological advancements, and collaborations among key market players.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp

What are the Key Market Players in Clinical Biomarkers Market and How They’re Evolving?

Major companies operating in the clinical biomarkers market include Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.

What Are the Primary Growth Drivers in the Clinical Biomarkers Market?

The growth of the clinical biomarker market is predicted to accelerate due to the high incidence of cancer. Cancer refers to a diverse range of conditions characterized by the uncontrolled growth and division of abnormal cells, which can potentially damage healthy tissues in the body. Clinical biomarkers perform an indispensable function in preventing cancer by assisting in the early discovery, risk evaluation, and tracking of individuals susceptible to developing cancer. For instance, Cancer Research UK, a UK-based cancer research institution, estimates that between 2023 and 2025, new cases of kidney cancer will experience a surge, increasing from around 16,300 to approximately 21,900 by the period of 2038–2040, translating to a 15% rise within this time frame. Consequently, the high frequency of cancer is propelling the expansion of the clinical biomarker market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12670&type=smp

What Are the Leading Segments in the Global Clinical Biomarkers Industry?

The clinical biomarkers market covered in this report is segmented –

1) By Offering: Product, Service

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies

3) By Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas

4) By Application: Clinical Diagnostic, Translational Research

5) By End User: Contract Research Organizations (CROs), Research And Academic Laboratories, Biopharmaceutical And Biotech Companies, Diagnostic Centers, Other End Users

Subsegments:

1) By Product: Diagnostic Kits, Reagents, Assay Kits, Instruments

2) By Service: Biomarker Discovery Services, Analytical Services, Clinical Trial Services, Data Analysis Services

What Are the Key Market Trends in the Clinical Biomarkers Industry?

The expansion of technological innovations is a growing trend within the clinical biomarker market. Top firms in this market are leveraging novel technologies to maintain their market status. Veravas Inc., a U.S-based medicine manufacturing company, for instance, introduced VeraBIND technology in June 2023. This technology offers a unique and thorough method that intensifies the accuracy of biomarker identification and minimizes the probability of false positive or negative outcomes across diverse sample types. By employing this technology, clinical labs have the capacity to enhance their diagnostic processes and contribute to the early detection of diseases, facilitating immediate and appropriate interventions. Furthermore, VeraBIND lays the groundwork for the swift development of assays, ensuring precision and uniformity in research, clinical trials, and diagnostic check-ups.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

What Is the Regional Outlook for the Clinical Biomarkers Market?

North America was the largest region in the clinical biomakers market in 2024. The regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12670

This Report Delivers Insight On:

1. How big is the clinical biomarkers market, and how is it changing globally?

2. Who are the major companies in the clinical biomarkers market, and how are they performing?

3. What are the key opportunities and risks in the clinical biomarkers market right now?

4. Which products or customer segments are growing the most in the clinical biomarkers market?

5. What factors are helping or slowing down the growth of the clinical biomarkers market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model